Despite its established role as a tumor suppressor in renal carcinomas,[122] these studies highlight an additional, distinct role for PBRM1 and other components of the SWI/SNF complex in modulating cancer cell susceptibility to immune destruction, features which may have important implications for the clinical application of immuno‐oncology agents.[121]. Here, PBRM1 is linked to cancer.